NCT06648447View on ClinicalTrials.gov

Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Keratoses With Downward-directed Proliferation Patterns

RecruitingOBSERVATIONAL

Enrollment

20

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions

Actinic Keratosis (AK)

Trial Locations (1)

42287

RECRUITING

CentroDerm, Wuppertal

All Listed Sponsors

lead

Thomas Dirschka

NETWORK